Managing Partner at Wellington Partners

Regina is a Managing Partner at Wellington Partners Life Sciences (WPLS) and represents the WPLS funds on the Boards of Ayoxxa, Carisma Therapeutics, Endostim, GTX Medical, Themis and TRiCares. She was a founding investor in Rigontec (acquired by MSD), Sapiens (acquired by Medtronic), Middle Peak Medical (acquired by Symetis / Boston Scientific), and an external director at GlaxoSmithKline’s Respiratory TA Board. Since joining the industry in 2000, she has become an influential investor in the European VC industry, focusing on early-stage and growth deals in Life Sciences. She currently serves as the Spokesperson for the Board of the German PE and VC Association (BVK).

Further stations of her career were Atlas Venture and Apax Partners, for which she served on several Boards, including Bicycle Therapeutics, F-star, U3 Pharma (acquired by Daiichi Sankyo), Nitec Pharma (now part of Horizon Pharma NASDAQ HZPN), Egalet (NASDAQ EGLT) and Novamed, (acquired by SciClone NASDAQ SCLN). Regina studied chemical engineering in Vienna and holds a PhD in biochemistry. She started to build her extensive network in the global healthcare industry during her tenure at McKinsey.